Top compounds associated with response to FAM229B


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0006
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0006
mRNA Vandetanib CCLE pan-cancer AAC -0.17 0.0009
mRNA VNLG/124 GDSC1000 pan-cancer AAC -0.12 0.001
mRNA 5-FU CTRPv2 pan-cancer AAC -0.12 0.001
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.001
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.001
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.001
mRNA PD-0325901 CCLE pan-cancer AAC -0.14 0.002
mRNA AC220 GDSC1000 pan-cancer AAC -0.12 0.002
Download CSV